سعر سوكروفيلمبان 1جم/5مل شراب معلق 120مل 2022

Sucralfate 1 g/5 ml oral suspension, 120 ml bottle (mucosal protectant antiulcer agent).

• Constipation most frequent (2%); others include diarrhea, nausea, vomiting, flatulence, dry mouth, pruritus, rash, dizziness, headache; post-marketing hypersensitivity including anaphylaxis, and bronchospasm/laryngeal edema reported.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to the active substance or any excipient.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Fatal complications including pulmonary and cerebral emboli occurred with inappropriate intravenous administration of sucralfate suspension; for oral use only.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Episodes of hyperglycemia reported in diabetic patients; monitor glycemia and adjust antidiabetic treatment if needed.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Aluminium accumulation and toxicity risk in chronic renal failure or dialysis; use with caution.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Cimetidine, digoxin, fluoroquinolones, ketoconazole, levothyroxine, phenytoin, quinidine, ranitidine, tetracycline, theophyllineSimultaneous administration reduced their absorption.DailyMed (U.S. National Library of Medicine)

• Animal studies up to 50 times the human dose showed no fetal harm; no adequate studies in pregnant women; use only if clearly needed.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk; caution in nursing women.General active-ingredient information · DailyMed (U.S. National Library of Medicine)